The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms
Open accessAbstract
Fucoidan is a polysaccharide built from L-fucose molecules. The main source of this polysaccharide is the extracellular matrix of brown seaweed (Phaeophyta), but it can be also isolated from invertebrates such as sea urchins (Echinoidea) and sea cucumbers (Holothuroidea). Interest in fucoidan is related to its broad biological activity, including possible antioxidant, anti-inflammatory, antifungal, antiviral or antithrombotic effects. The potential application of fucoidan in the pharmaceutical technology is also due to its ionic nature. The negative charge of the molecule results from the presence of sulfate residues in the C-2 and C-4 positions, occasionally in C-3, allowing the formation of complexes with other oppositely charged molecules. Fucoidan is non-toxic, biodegradable and biocompatible compound approved by Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS) category as food ingredient. Fucoidan plays an important role in the pharmaceutical technology, so in this work aspects concerning its pharmaceutical characteristics and designing of various dosage forms (nanoparticles, liposomes, microparticles, and semisolid formulations) with fucoidan itself and with its combinations with other polymers or components that give a positive charge were reviewed. Advantages and limitations of fucoidan utilization in the pharmaceutical technology were also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“The main reason for the use of liposomes is the possibility of targeted therapy, which in addition to the improved effectiveness of the treatment, allows to reduce drug side effects [69].”
BackgroundTherapies from Fucoidan: An Update
Fitton, J., Stringer, D., & Karpiniec, S. (2015) · Marine Drugs · doi:10.3390/md13095920 · Cited by 418
Garcia-Vaquero, M., Rajauria, G., O'Doherty, J. V., & Sweeney, T. (2017) · Food Research International · doi:10.1016/j.foodres.2016.11.016 · Cited by 364
Fernando, I. P. S., Sanjeewa, K. K. A., Samarakoon, K. W., Lee, W. W., Kim, H.-S., Kang, N., Ranasinghe, P., Lee, H.-S., & Jeon, Y.-J. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.031 · Cited by 157 · cited 2×
“It was found that some fucoidans might exhibit antioxidant [9], anticoagulant [10], antibacterial [11,12], antifungal, antileishmanial [12], anti-inflammatory, and immunomodulatory [13] activity.”
BackgroundTsai, H.-L., Tai, C.-J., Huang, C.-W., Chang, F.-R., & Wang, J.-Y. (2017) · Marine Drugs · doi:10.3390/md15040122 · Cited by 156
Tocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71 · cited 1×
“in enhancing the therapeutic effects of conventional anti-cancer therapies [16,17].”
BackgroundSynergistic effect of fucoidan with antibiotics against oral pathogenic bacteria
Lee, K.-Y., Jeong, M.-R., Choi, S.-M., Na, S.-S., & Cha, J.-D. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.11.002 · Cited by 65
Genotoxicity studies on fucoidan from Sporophyll of Undaria pinnatifida
Kim, K.-J., Lee, O.-H., & Lee, B.-Y. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.01.032 · Cited by 55
Cited by
Immunomodulatory and Anti-Inflammatory Effects of Fucoidan: A Review
Apostolova, E., Lukova, P., Baldzhieva, A., Katsarov, P., Nikolova, M., Iliev, I., Peychev, L., Trica, B., Oancea, F., Delattre, C., et al. (2020) · Polymers · doi:10.3390/polym12102338 · Cited by 345
Therapies from Fucoidan: New Developments
Fitton, J. H., Stringer, D. N., Park, A. Y., & Karpiniec, S. S. (2019) · Marine Drugs · doi:10.3390/md17100571 · Cited by 225
Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics
López-Hortas, L., Flórez-Fernández, N., Torres, M. D., Ferreira-Anta, T., Casas, M. P., Balboa, E. M., Falqué, E., & Domínguez, H. (2021) · Marine Drugs · doi:10.3390/md19100552 · Cited by 168
Fucoidan in pharmaceutical formulations: A comprehensive review for smart drug delivery systems
Haggag, Y., Abd Elrahman, A., Ulber, R., & Zayed, A. (2023) · Marine Drugs · doi:10.3390/md21020112 · Cited by 126
Tocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71
Metadata
- Authors
- Citkowska, A., Szekalska, M., & Winnicka, K.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-05
- Volume
- 17
- Issue
- 8
- Pages
- 458
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2964822268
- Cited by
- 211
- References
- 8
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms. https://app.cochat.ai/papers/10.3390/md17080458
- The paper
- Citkowska, A., Szekalska, M., & Winnicka, K. (2019). Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms. Marine Drugs. https://doi.org/10.3390/md17080458
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.